Statistics
Publications
35
Citations
9K
H-Index
28
Active since
1998
Jordan S. Fridman is an author at Incyte (United States) specializing in medicine, pharmacology, and molecular oncology.
Publications per year
1998–2017
35
35
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text
Medicine, Hematology, Pharmacology +13
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Clemens A. Schmitt, Jordan S. Fridman, Meng Yang et al. · Cell · 2002 · 1K citations · Full text
Medicine, Cancer Biology, Oncology +16
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Hans-Guido Wendel, Elisa de Stanchina, Jordan S. Fridman et al. · Nature · 2004 · 947 citations
Medicine, Cancer Biology, Oncology +14
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 559 citations · Full text
Medicine, Immunology, Oncology +14
1–5 of 35